Mipasteone Kids Blue Raspberry

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the prevention of dental cavities.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children aged 2 years and older, a small, pea-sized amount of MI Paste ONE Kids should be applied to the toothbrush. It is recommended to brush for a duration of 2 minutes, followed by expectoration. Patients should avoid eating or drinking for 30 minutes after brushing to maximize the effectiveness of the product.

The application of MI Paste ONE Kids should occur twice daily. For children under 2 years of age, it is advised to consult a dentist or physician prior to use.

Contraindications

Use is contraindicated in patients with a known allergy to milk proteins or hydroxybenzoates.

Additionally, the product should not be used in children under 6 years of age. In the event of accidental ingestion of more than the recommended amount, immediate medical assistance or contact with a Poison Control Center is advised. If an allergic reaction occurs, discontinue use, rinse the mouth with water, and seek medical advice.

Warnings and Precautions

It is imperative to keep this product out of reach of children under 6 years of age to prevent accidental ingestion. In the event that more than the recommended amount of paste is swallowed, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

This product is contraindicated in patients with known allergies to milk proteins or hydroxybenzoates. Healthcare professionals should exercise caution and ensure that patients are screened for these allergies prior to use.

In the occurrence of an allergic reaction, it is essential to discontinue use immediately. Patients should rinse their mouths thoroughly with water and seek medical advice to address any adverse effects. Monitoring for signs of allergic reactions is advised to ensure patient safety.

Side Effects

Patients may experience allergic reactions to the product, particularly those with a known allergy to milk protein or hydroxybenzoates. In the event of an allergic reaction, it is advised to discontinue use immediately, rinse the mouth with water, and seek medical advice.

Accidental ingestion of the product, especially if more than the recommended amount of paste is used for brushing, may necessitate immediate medical assistance or contact with a Poison Control Center.

Additionally, it is important to keep the product out of reach of children under 6 years of age to prevent any potential adverse effects associated with inappropriate use.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Mipasteone Kids Blue Raspberry (mi paste one kids blue raspberry). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

For pediatric patients aged 2 years and older, a small, pea-size amount of MI Paste ONE Kids should be applied to the toothbrush for use. In children under 2 years of age, it is advised to consult a dentist or physician prior to use.

Caution is warranted as MI Paste ONE Kids should be kept out of reach of children under 6 years of age. In the event that more than the recommended amount of paste is accidentally swallowed, immediate medical assistance should be sought or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of MI Paste ONE Kids during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use. There are no adequate and well-controlled studies in pregnant women, and potential risks to the fetus cannot be ruled out. No specific dosage modifications for pregnant women are provided; therefore, it is advisable for healthcare professionals to offer guidance tailored to individual circumstances.

Lactation

Nursing mothers should consult a healthcare professional before using MI Paste ONE Kids. There is a potential for excretion in breast milk; therefore, caution is advised when administering this product to lactating mothers. The safety of MI Paste ONE Kids during lactation has not been established.

Renal Impairment

There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If an individual accidentally swallows more than the recommended amount of the paste, it is imperative to seek medical help or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt intervention can mitigate potential adverse effects associated with overdosage. Monitoring the patient for any symptoms that may arise is essential, although specific symptoms related to overdosage are not detailed in the available data.

Management of overdosage should focus on supportive care and symptomatic treatment as necessary. It is advisable to follow established protocols for the management of overdose cases, ensuring that the patient receives appropriate evaluation and treatment based on their clinical presentation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: allergic reactions, which include manifestations such as rash, itching, and swelling.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children under 6 years of age to prevent accidental ingestion. Instruct patients that if more than the recommended amount of paste is accidentally swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is important to inform patients not to use this product if they have a known allergy to milk protein or hydroxybenzoates. In the event of an allergic reaction, patients should be instructed to stop using the product, rinse their mouth with water, and seek medical advice promptly.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is recommended to store the product at room temperature to maintain its efficacy and stability.

After each use, it is crucial to securely replace the cap to prevent contamination and preserve the integrity of the product. Additionally, to ensure safety, the product should be kept out of reach of children under 6 years of age. Proper handling and storage practices are vital for optimal product performance and safety.

Additional Clinical Information

For patients aged 2 years and older, MI Paste ONE Kids should be administered via the dental route. A small, pea-sized amount is to be applied to the toothbrush, with a recommended brushing duration of 2 minutes. Patients are advised to expectorate and refrain from eating or drinking for 30 minutes post-brushing. This application should occur twice daily.

Clinicians should counsel patients to keep the product out of reach of children under 6 years of age. In the event of accidental ingestion of more than the recommended amount, immediate medical assistance or contact with a Poison Control Center is necessary. The product is contraindicated in individuals with allergies to milk proteins or hydroxybenzoates. Should an allergic reaction occur, patients should discontinue use, rinse their mouth with water, and seek medical advice.

Drug Information (PDF)

This file contains official product information for Mipasteone Kids Blue Raspberry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)